Encompass Health Corporation $EHC Shares Sold by Cwm LLC

Cwm LLC reduced its stake in shares of Encompass Health Corporation (NYSE:EHC) by 46.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,708 shares of the company’s stock after selling 8,431 shares during the period. Cwm LLC’s holdings in Encompass Health were worth $1,030,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Citizens National Bank Trust Department acquired a new stake in shares of Encompass Health during the 3rd quarter valued at about $26,000. First Horizon Corp purchased a new position in Encompass Health in the 3rd quarter valued at about $34,000. Westside Investment Management Inc. lifted its stake in Encompass Health by 56.7% in the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after buying an additional 101 shares in the last quarter. Flagship Harbor Advisors LLC purchased a new position in Encompass Health in the 4th quarter worth approximately $37,000. Finally, Assetmark Inc. lifted its stake in Encompass Health by 88.1% in the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after purchasing an additional 140 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the sale, the chief executive officer directly owned 377,070 shares of the company’s stock, valued at $42,096,094.80. The trade was a 28.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Treasurer Edmund Fay sold 11,937 shares of the business’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the sale, the treasurer directly owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.80% of the company’s stock.

Encompass Health Stock Performance

NYSE:EHC opened at $101.08 on Tuesday. The company has a fifty day simple moving average of $103.48 and a two-hundred day simple moving average of $107.88. The company has a market cap of $10.05 billion, a price-to-earnings ratio of 18.25, a price-to-earnings-growth ratio of 1.95 and a beta of 0.75. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.29 by $0.17. The business had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.17 earnings per share. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, equities analysts anticipate that Encompass Health Corporation will post 5.91 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were paid a dividend of $0.19 per share. The ex-dividend date was Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.8%. Encompass Health’s payout ratio is presently 13.72%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Wall Street Zen lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday, April 11th. Barclays lifted their price target on shares of Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research report on Friday, February 6th. Two analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $146.33.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.